Trial reportMedicine2025
Research on Internet plus continuing nursing under dual heart medical model after percutaneous coronary intervention.
Trial report in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DynamX Bioadaptor as an Emerging and Promising Innovation in Interventional Cardiology.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary heart disease (CHD) remains a prevalent and chronic cardiovascular disorder with a persistently rising global incidence and mortality rate. This study evaluates the clinical outcomes of an internet-based continuous nursing intervention for CHD patients following percutaneous coronary intervention. A cohort of 60 CHD patients admitted to our hospital between June 2023 and April 2024 were enrolled as study subjects. Using a randomized number table method, they were allocated into a control group and an observation group, with 30 patients in each. The control group received standard care, whereas the observation group underwent an integrated dual-medical model combining internet-based support with structured continuous nursing. Comparison metrics included anxiety scores (e.g., Hospital Anxiety and Depression Scale), depression scores, SF-36 quality-of-life assessments, medication adherence, cardiac function parameters (left ventricular ejection fraction, left ventricular diastolic dysfunction), and rates of cardiovascular adverse events. Post-intervention, exhibited significant reductions in anxiety and depression scores, with the observation group demonstrating markedly lower scores than the control group (P < .05). The observation group also achieved superior SF-36 scores across all domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health (P < .05). While medication adherence at 1 month showed no statistical difference between groups (P > .05), the observation group displayed significantly higher compliance at 2 and 4 months (P < .05). Cardiac function improved in both groups, with the observation group achieving greater enhancements in left ventricular ejection fraction and left ventricular diastolic dysfunction (P < .05). The dual-medical model integrating internet-based continuous nursing significantly enhances cardiac rehabilitation, optimizes medication adherence, elevates quality of life, alleviates psychological distress, and reduces cardiovascular complications in post-percutaneous coronary intervention patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.